Recent Finacing
Recent Raise
Aktis Oncology is a clinical-stage biotech developing targeted alpha radiopharmaceuticals for solid tumors using an isotope-agnostic miniprotein radioconjugate platform enabling imaging-verified target engagement; lead program targets Nectin-4.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
